Szostak M Anne - May 5, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for M. Anne Szostak
Stock symbol
IDXX
Transactions as of
May 5, 2023
Transactions value $
-$949,789
Form type
4
Date filed
5/8/2023, 05:03 PM
Previous filing
Feb 10, 2023
Next filing
May 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Sale -$332K -700 -10.45% $473.59 6K May 5, 2023 Trust of M. Anne Szostak F1, F2
transaction IDXX Common Stock Sale -$380K -800 -13.33% $475.27 5.2K May 5, 2023 Trust of M. Anne Szostak F2, F3
transaction IDXX Common Stock Sale -$238K -500 -9.62% $476.12 4.7K May 5, 2023 Trust of M. Anne Szostak F2, F4
holding IDXX Common Stock 1.26K May 5, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $473.17 to a high of $474.13 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.
F3 Represents the weighted average price of the shares sold ranging from a low of $474.67 to a high of $475.66 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $475.84 to a high of $476.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.